Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.8 |
mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | 0.0089 | 0.8 |
mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.8 |
mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.0081 | 0.8 |
mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.0077 | 0.8 |
mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.8 |
mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.8 |